Reactive oxygen species (ROS)-mediated M1 macrophage-dependent nanomedicine remodels inflammatory microenvironment for osteoarthritis recession
Osteoarthritis (OA) is a common chronic inflammatory disorder. Effective remodeling of inflammatory microenvironment in the joint is a promising strategy to prevent OA. However, current drugs remain unsatisfactory due to a lack of targeted and effective ways for relieving inflammatory conditions in...
Main Authors: | Chunchun Xue, Jia Tian, Zepeng Cui, Yang Liu, Dawei Sun, Mengting Xiong, Nanxing Yi, Kaiqiang Wang, Xiaofeng Li, Yongjun Wang, Hao Xu, Weian Zhang, Qianqian Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2024-03-01
|
Series: | Bioactive Materials |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X2300347X |
Similar Items
-
Analysis of Nanomedicine Efficacy for Osteoarthritis
by: Yuwen Wang, et al.
Published: (2022-12-01) -
Bone Remodeling in Osteoarthritis—Biological and Radiological Aspects
by: Luka Dudaric, et al.
Published: (2023-09-01) -
Nanomedicines Reprogram Synovial Macrophages by Scavenging Nitric Oxide and Silencing CA9 in Progressive Osteoarthritis
by: Yi Yan, et al.
Published: (2023-04-01) -
Denosumab ameliorates osteoarthritis by protecting cartilage against degradation and modulating subchondral bone remodeling
by: Lei Shangguan, et al.
Published: (2024-12-01) -
Reprogramming Macrophage Polarization, Depleting ROS by Astaxanthin and Thioketal‐Containing Polymers Delivering Rapamycin for Osteoarthritis Treatment
by: Huiyun Li, et al.
Published: (2024-03-01)